This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akiyama, Y.
Right arrow Articles by Baylin, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akiyama, Y.
Right arrow Articles by Baylin, S. B.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, December 2003, p. 8429-8439, Vol. 23, No. 23
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.23.8429-8439.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

GATA-4 and GATA-5 Transcription Factor Genes and Potential Downstream Antitumor Target Genes Are Epigenetically Silenced in Colorectal and Gastric Cancer

Yoshimitsu Akiyama,1 Neil Watkins,1 Hiromu Suzuki,1 Kam-Wing Jair,1 Manon van Engeland,1,3 Manel Esteller,1,4 Hidekazu Sakai,2 Chun-Yan Ren,2 Yasuhito Yuasa,2 James G. Herman,1 and Stephen B. Baylin1*

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231,1 Department of Molecular Oncology, Tokyo Medical and Dental University, Tokyo 113-8519, Japan,2 Department of Pathology, University Maastricht, 6200 MD Maastricht, The Netherlands,3 Cancer Epigenetics Laboratory, Spanish National Cancer Center, 28029 Madrid, Spain4

Received 1 July 2003/ Accepted 15 August 2003

The GATA family of transcription factors participates in gastrointestinal (GI) development. Increases in GATA-4 and -5 expression occur in differentiation and GATA-6 expression in proliferation in embryonic and adult settings. We now show that in colorectal cancer (CRC) and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 but are never seen for GATA-6. Potential antitumor target genes upregulated by GATA-4 and -5, the trefoil factors, inhibin{alpha}, and disabled-2 (Dab2) are also silenced, in GI cancers, with associated methylation of the promoters. Drug or genetically induced demethylation simultaneously leads to expression, in CRC cells, of all of the GATA-4, -5, and downstream genes. Expression of exogenous GATA-5 overrides methylation at the downstream promoters to activate the target genes. Selection for silencing of both upstream transcription factors and their target genes in GI cancers could indicate that epigenetic silencing of the involved genes provides a summated contribution to tumor progression.


* Corresponding author. Mailing address: Bunting-Blaustein Cancer Research Building, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans St., Baltimore, MD 21231. Phone: (410) 955-8506. Fax: (410) 614-9884. E-mail: sbaylin{at}jhmi.edu.


Molecular and Cellular Biology, December 2003, p. 8429-8439, Vol. 23, No. 23
0022-538X/03/$08.00+0     DOI: 10.1128/MCB.23.23.8429-8439.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Hellebrekers, D. M.E.I., Lentjes, M. H.F.M., van den Bosch, S. M., Melotte, V., Wouters, K. A.D., Daenen, K. L.J., Smits, K. M., Akiyama, Y., Yuasa, Y., Sanduleanu, S., Khalid-de Bakker, C. A.J., Jonkers, D., Weijenberg, M. P., Louwagie, J., van Criekinge, W., Carvalho, B., Meijer, G. A., Baylin, S. B., Herman, J. G., de Bruine, A. P., van Engeland, M. (2009). GATA4 and GATA5 are Potential Tumor Suppressors and Biomarkers in Colorectal Cancer. Clin. Cancer Res. 15: 3990-3997 [Abstract] [Full Text]  
  • Lindholm, P M, Soini, Y, Myllarniemi, M, Knuutila, S, Heikinheimo, M, Kinnula, V L, Salmenkivi, K (2009). Expression of GATA-6 transcription factor in pleural malignant mesothelioma and metastatic pulmonary adenocarcinoma. J. Clin. Pathol. 62: 339-344 [Abstract] [Full Text]  
  • Tanemura, A., Terando, A. M., Sim, M.-S., van Hoesel, A. Q., de Maat, M. F.G., Morton, D. L., Hoon, D. S.B. (2009). CpG Island Methylator Phenotype Predicts Progression of Malignant Melanoma. Clin. Cancer Res. 15: 1801-1807 [Abstract] [Full Text]  
  • Derks, S., Postma, C., Carvalho, B., van den Bosch, S. M., Moerkerk, P. T.M., Herman, J. G., Weijenberg, M. P., de Bruine, A. P., Meijer, G. A., van Engeland, M. (2008). Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations. Carcinogenesis 29: 434-439 [Abstract] [Full Text]  
  • Yamashita, K., Kim, M. S., Park, H. L., Tokumaru, Y., Osada, M., Inoue, H., Mori, M., Sidransky, D. (2008). HOP/OB1/NECC1 Promoter DNA Is Frequently Hypermethylated and Involved in Tumorigenic Ability in Esophageal Squamous Cell Carcinoma. Mol Cancer Res 6: 31-41 [Abstract] [Full Text]  
  • Zou, H., Harrington, J. J., Shire, A. M., Rego, R. L., Wang, L., Campbell, M. E., Oberg, A. L., Ahlquist, D. A. (2007). Highly Methylated Genes in Colorectal Neoplasia: Implications for Screening. Cancer Epidemiol. Biomarkers Prev. 16: 2686-2696 [Abstract] [Full Text]  
  • Sato, H., Suzuki, H., Toyota, M., Nojima, M., Maruyama, R., Sasaki, S., Takagi, H., Sogabe, Y., Sasaki, Y., Idogawa, M., Sonoda, T., Mori, M., Imai, K., Tokino, T., Shinomura, Y. (2007). Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. Carcinogenesis 28: 2459-2466 [Abstract] [Full Text]  
  • Jonckheere, N., Vincent, A., Perrais, M., Ducourouble, M.-P., Male, A. K.-v., Aubert, J.-P., Pigny, P., Carraway, K. L., Freund, J.-N., Renes, I. B., Van Seuningen, I. (2007). The Human Mucin MUC4 Is Transcriptionally Regulated by Caudal-related Homeobox, Hepatocyte Nuclear Factors, Forkhead Box A, and GATA Endodermal Transcription Factors in Epithelial Cancer Cells. J. Biol. Chem. 282: 22638-22650 [Abstract] [Full Text]  
  • Huang, Y., Greene, E., Murray Stewart, T., Goodwin, A. C., Baylin, S. B., Woster, P. M., Casero, R. A. Jr (2007). Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes. Proc. Natl. Acad. Sci. USA 104: 8023-8028 [Abstract] [Full Text]  
  • Lehner, F., Kulik, U., Klempnauer, J., Borlak, J. (2007). The hepatocyte nuclear factor 6 (HNF6) and FOXA2 are key regulators in colorectal liver metastases. FASEB J. 21: 1445-1462 [Abstract] [Full Text]  
  • Shureiqi, I., Zuo, X., Broaddus, R., Wu, Y., Guan, B., Morris, J. S., Lippman, S. M. (2007). The transcription factor GATA-6 is overexpressed in vivo and contributes to silencing 15-LOX-1 in vitro in human colon cancer. FASEB J. 21: 743-753 [Abstract] [Full Text]  
  • Ting, A. H., McGarvey, K. M., Baylin, S. B. (2006). The cancer epigenome--components and functional correlates. Genes Dev. 20: 3215-3231 [Abstract] [Full Text]  
  • McGarvey, K. M., Fahrner, J. A., Greene, E., Martens, J., Jenuwein, T., Baylin, S. B. (2006). Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state.. Cancer Res. 66: 3541-3549 [Abstract] [Full Text]  
  • Ting, A. H., Jair, K.-w., Schuebel, K. E., Baylin, S. B. (2006). Differential Requirement for DNA Methyltransferase 1 in Maintaining Human Cancer Cell Gene Promoter Hypermethylation. Cancer Res. 66: 729-735 [Abstract] [Full Text]  
  • Brock, M. V., Hooker, C. M., Yung, R., Guo, M., Han, Y., Ames, S. E., Chang, D., Yang, S. C., Mason, D., Sussman, M., Baylin, S. B., Herman, J. G. (2005). Can We Improve the Cytologic Examination of Malignant Pleural Effusions Using Molecular Analysis?. Ann. Thorac. Surg. 80: 1241-1247 [Abstract] [Full Text]  
  • Oskouian, B., Mendel, J., Shocron, E., Lee, M. A. Jr., Fyrst, H., Saba, J. D. (2005). Regulation of Sphingosine-1-phosphate Lyase Gene Expression by Members of the GATA Family of Transcription Factors. J. Biol. Chem. 280: 18403-18410 [Abstract] [Full Text]  
  • HERMAN, J.G. (2005). Epigenetic Changes in Cancer and Preneoplasia. Cold Spring Harb Symp Quant Biol 70: 329-333 [Abstract]  
  • Yuasa, Y., Nagasaki, H., Akiyama, Y., Sakai, H., Nakajima, T., Ohkura, Y., Takizawa, T., Koike, M., Tani, M., Iwai, T., Sugihara, K., Imai, K., Nakachi, K. (2005). Relationship between CDX2 gene methylation and dietary factors in gastric cancer patients. Carcinogenesis 26: 193-200 [Abstract] [Full Text]  
  • Guo, M., Akiyama, Y., House, M. G., Hooker, C. M., Heath, E., Gabrielson, E., Yang, S. C., Han, Y., Baylin, S. B., Herman, J. G., Brock, M. V. (2004). Hypermethylation of the GATA Genes in Lung Cancer. Clin. Cancer Res. 10: 7917-7924 [Abstract] [Full Text]  
  • Kim, J. S., Kim, H., Shim, Y. M., Han, J., Park, J., Kim, D.-H. (2004). Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung. Carcinogenesis 25: 2165-2171 [Abstract] [Full Text]  
  • Douglas, D. B., Akiyama, Y., Carraway, H., Belinsky, S. A., Esteller, M., Gabrielson, E., Weitzman, S., Williams, T., Herman, J. G., Baylin, S. B. (2004). Hypermethylation of a Small CpGuanine-Rich Region Correlates with Loss of Activator Protein-2{alpha} Expression during Progression of Breast Cancer. Cancer Res. 64: 1611-1620 [Abstract] [Full Text]